Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03551873 · ClinicalTrials.gov registry record
A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®
A clinical trial, sponsored by Bausch Health Americas.
- Completed
- Registry status
- 7
- Enrollment target
NCT03551873: Completed study, sponsored by Bausch Health Americas.
NCT03551873 is a clinical trial that has completed, run by Bausch Health Americas. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03551873 has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a multi-center, open-label study evaluating pharmacokinetics of TRULANCE® (plecanatide) in breast milk of lactating women treated with TRULANCE
Primary Outcome
Maximum observed concentration of TRULANCE (plecanatide) in breast milk during a dosing interval at steady state
Interventions
- DRUG Plecanatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2018-12-14 |
What the finished NCT03551873 record still lists
NCT03551873 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Plecanatide is the first listed.
NCT03551873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03551873 about?
NCT03551873 is a clinical study titled "A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®". This is a multi-center, open-label study evaluating pharmacokinetics of TRULANCE® (plecanatide) in breast milk of lactating women treated with TRULANCE
What is the current status of trial NCT03551873?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2018-06-21. Estimated completion is 2018-12-14.
What interventions are being tested in trial NCT03551873?
The interventions under investigation include: Plecanatide (DRUG).
Who is sponsoring clinical trial NCT03551873?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI